Cardiovascular Mortality After Type 1 and Type 2 Myocardial Infarction in Young Adults

Avinainder Singh1, Ankur Gupta2, Ersilia M DeFilippis3

  • 1Department of Medicine, Yale University School of Medicine, New Haven, Connecticut. Electronic address: https://twitter.com/AvinainderSingh.

Insights

Young adults with type 2 myocardial infarction (MI) or myocardial injury face higher long-term mortality than type 1 MI. Aggressive secondary prevention is crucial for these patients.

Area of Science:

  • Cardiology
  • Clinical Medicine
  • Public Health

Background:

  • Type 2 myocardial infarction (MI) and myocardial injury are linked to increased short-term mortality.
  • Long-term mortality data for these conditions in young adults are limited.

Purpose of the Study:

  • To compare long-term mortality among young adults (≤50 years) diagnosed with type 1 MI, type 2 MI, or myocardial injury.
  • To identify differences in mortality risk and clinical characteristics across these MI types.

Main Methods:

  • A cohort of 3,829 young adults diagnosed with MI or myocardial injury over 17 years was analyzed.
  • Patients were categorized based on the Fourth Universal Definition of MI.
  • Cox proportional hazards models assessed all-cause and cardiovascular death risk.

Main Results:

  • Mortality was highest for myocardial injury (45.6%), followed by type 2 MI (34.2%), and type 1 MI (12%) over 10.2 years.
  • Type 2 MI was associated with significantly higher all-cause and cardiovascular mortality compared to type 1 MI.
  • Patients with type 2 MI/myocardial injury were younger, had fewer cardiovascular risk factors, but more noncardiovascular comorbidities.

Conclusions:

  • Young patients with type 2 MI face elevated long-term mortality risks compared to type 1 MI.
  • Nearly half of myocardial injury patients and over a third of type 2 MI patients died within 10 years.
  • Enhanced secondary prevention strategies are essential for type 2 MI and myocardial injury patients.
Abstract

Related Concept Videos

Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
2.6K
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
300
Exercise and Cardiovascular Response01:20

Exercise and Cardiovascular Response

Exercise significantly impacts cardiovascular response, which is crucial for understanding patient health and designing effective treatment plans.
Light to moderate physical activity initiates a series of interconnected responses in the body. The heart rate modestly increases in anticipation of the workout, followed by widespread vasodilation as oxygen consumption by skeletal muscles increases. This results in decreased peripheral resistance, increased capillary blood flow, and accelerated...
3.8K
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
295
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
284
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
248